{
  "trial_id": "NCT03829046",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, history of clinical ASCVD, clinical diagnosis of type 2 diabetes, dose of statin therapy, LDL-c levels, fasting triglycerides levels, urinary Albumin Creatinine Ratio (ACR), personal or family history of hereditary muscular disorders, NYHA heart failure classification, left ventricular ejection fraction (LVEF), history of cardiac arrhythmia, myocardial infarction history, renal function (eGFR), HbA1c levels, blood pressure (systolic and diastolic), use of cholesterol ester transfer protein (CETP) inhibitors, use of systemic cyclosporine or steroids, thyroid stimulating hormone (TSH) levels, liver function (AST and ALT levels), history of deep vein thrombosis or pulmonary embolism, alcohol or drug abuse history, participation in other investigational studies, use of contraception, pregnancy status, BMI.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Diabetes",
          "clinical diagnosis of type 2 diabetes"
        ],
        [
          "Cardiovascular Disease (CVD)",
          "history of clinical ASCVD"
        ],
        [
          "Medication Use",
          "dose of statin therapy"
        ],
        [
          "Cholesterol Panel",
          "LDL-c levels"
        ],
        [
          "Albumin",
          "urinary Albumin Creatinine Ratio (ACR)"
        ],
        [
          "HbA1c (glycated hemoglobin)",
          "HbA1c levels"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Smoking",
        "Hypertension",
        "Family History",
        "Fibrinogen"
      ],
      "remaining_candidate_features": [
        "personal or family history of hereditary muscular disorders",
        "NYHA heart failure classification",
        "left ventricular ejection fraction (LVEF)",
        "history of cardiac arrhythmia",
        "myocardial infarction history",
        "renal function (eGFR)",
        "fasting triglycerides levels",
        "blood pressure (systolic and diastolic)",
        "use of cholesterol ester transfer protein (CETP) inhibitors",
        "use of systemic cyclosporine or steroids",
        "thyroid stimulating hormone (TSH) levels",
        "liver function (AST and ALT levels)",
        "history of deep vein thrombosis or pulmonary embolism",
        "alcohol or drug abuse history",
        "participation in other investigational studies",
        "use of contraception",
        "pregnancy status",
        "BMI"
      ]
    },
    "processed-gen-response": "Age, gender, history of clinical ASCVD, clinical diagnosis of type 2 diabetes, dose of statin therapy, LDL-c levels, fasting triglycerides levels, urinary Albumin Creatinine Ratio (ACR), personal or family history of hereditary muscular disorders, NYHA heart failure classification, left ventricular ejection fraction (LVEF), history of cardiac arrhythmia, myocardial infarction history, renal function (eGFR), HbA1c levels, blood pressure (systolic and diastolic), use of cholesterol ester transfer protein (CETP) inhibitors, use of systemic cyclosporine or steroids, thyroid stimulating hormone (TSH) levels, liver function (AST and ALT levels), history of deep vein thrombosis or pulmonary embolism, alcohol or drug abuse history, participation in other investigational studies, use of contraception, pregnancy status, BMI."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, LDL cholesterol, HDL cholesterol, Triglycerides, HbA1c, Duration of Diabetes, Smoking Status, History of Cardiovascular Disease, Estimated Glomerular Filtration Rate (eGFR), Urinary Albumin Creatinine Ratio (ACR),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Diabetes",
          "Duration of Diabetes"
        ],
        [
          "Hypertension",
          "Systolic Blood Pressure"
        ],
        [
          "Cardiovascular Disease (CVD)",
          "History of Cardiovascular Disease"
        ],
        [
          "Medication Use",
          "LDL cholesterol"
        ],
        [
          "Cholesterol Panel",
          "HDL cholesterol"
        ],
        [
          "HbA1c (glycated hemoglobin)",
          "HbA1c"
        ],
        [
          "Smoking",
          "Smoking Status"
        ],
        [
          "Albumin",
          "Urinary Albumin Creatinine Ratio (ACR)"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Family History",
        "Fibrinogen"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Body Mass Index",
        "Diastolic Blood Pressure",
        "Triglycerides",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, LDL cholesterol, HDL cholesterol, Triglycerides, HbA1c, Duration of Diabetes, Smoking Status, History of Cardiovascular Disease, Estimated Glomerular Filtration Rate (eGFR), Urinary Albumin Creatinine Ratio (ACR)"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, Existing Cardiovascular Disease, Baseline LDL-C, Baseline Triglycerides, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, eGFR, Urinary Albumin Creatinine Ratio.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Diabetes",
          "Diabetes Diagnosis Duration"
        ],
        [
          "Cardiovascular Disease (CVD)",
          "Existing Cardiovascular Disease"
        ],
        [
          "Cholesterol Panel",
          "Baseline LDL-C"
        ],
        [
          "HbA1c (glycated hemoglobin)",
          "HbA1c"
        ],
        [
          "Albumin",
          "Urinary Albumin Creatinine Ratio"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Smoking",
        "Hypertension",
        "Family History",
        "Medication Use",
        "Fibrinogen"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Baseline Triglycerides",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "eGFR"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes Diagnosis Duration, Existing Cardiovascular Disease, Baseline LDL-C, Baseline Triglycerides, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, eGFR, Urinary Albumin Creatinine Ratio."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, BMI, systolic blood pressure, diastolic blood pressure, heart rate, medical history (including ASCVD, type 2 diabetes, microvascular dysfunction), smoking status, lipid profile (including LDL-c, triglycerides, Lp(a), oxidized phospholipids, ApoB), HbA1c, urinary Albumin Creatinine Ratio (ACR), estimated glomerular filtration rate (eGFR), left ventricular ejection fraction (LVEF), NYHA class, statin use, other concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Smoking",
          "smoking status"
        ],
        [
          "Diabetes",
          "medical history (including ASCVD, type 2 diabetes, microvascular dysfunction)"
        ],
        [
          "Hypertension",
          "systolic blood pressure"
        ],
        [
          "Cardiovascular Disease (CVD)",
          "medical history (including ASCVD, type 2 diabetes, microvascular dysfunction)"
        ],
        [
          "Medication Use",
          "other concomitant medications"
        ],
        [
          "Cholesterol Panel",
          "lipid profile (including LDL-c, triglycerides, Lp(a), oxidized phospholipids, ApoB)"
        ],
        [
          "Albumin",
          "urinary Albumin Creatinine Ratio (ACR)"
        ],
        [
          "HbA1c (glycated hemoglobin)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Family History",
        "Fibrinogen"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "BMI",
        "diastolic blood pressure",
        "heart rate",
        "estimated glomerular filtration rate (eGFR)",
        "left ventricular ejection fraction (LVEF)",
        "NYHA class",
        "statin use"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, BMI, systolic blood pressure, diastolic blood pressure, heart rate, medical history (including ASCVD, type 2 diabetes, microvascular dysfunction), smoking status, lipid profile (including LDL-c, triglycerides, Lp(a), oxidized phospholipids, ApoB), HbA1c, urinary Albumin Creatinine Ratio (ACR), estimated glomerular filtration rate (eGFR), left ventricular ejection fraction (LVEF), NYHA class, statin use, other concomitant medications."
  }
}